首页> 外文期刊>Intelligence: A Multidisciplinary Journal >The differential impact of non-anthracycline treatment regimens on pathological complete response (pCR) rates by ER status after neoadjuvant single or dual HER2 targeted therapy (NACT): A single centre experience

【24h】

The differential impact of non-anthracycline treatment regimens on pathological complete response (pCR) rates by ER status after neoadjuvant single or dual HER2 targeted therapy (NACT): A single centre experience

机译：非蒽环治疗方案对Neoadjuvant单身或双HER2靶向治疗（NACT）后ER状态对病理完全反应（PCR）率的差异影响（PCR）：单一中心经验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献

1. The differential impact of non-anthracycline treatment regimens on pathological complete response (pCR) rates by ER status after neoadjuvant single or dual HER2 targeted therapy (NACT): A single centre experience [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：非蒽环治疗方案对Neoadjuvant单身或双HER2靶向治疗（NACT）后ER状态对病理完全反应（PCR）率的差异影响（PCR）：单一中心经验
2. Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies [J] . Sinead Toomey, Alexander J. Eustace, Joanna Fay, Breast Cancer Research . 2017,第1期

机译：体细胞PI3K途径和ERBB家族突变对接受新辅助HER2靶向治疗的HER2阳性乳腺癌患者的病理完全缓解（pCR）的影响
3. Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials [J] . BriaE., CarbogninL., FurlanettoJ., Cancer Treatment Reviews . 2014,第7期

机译：新辅助单或双HER2抑制和化疗骨架对可手术和局部晚期乳腺癌病理完全缓解的影响：随机试验的敏感性分析
4. Baseline oxygen saturation comparison between pathologic complete responders and extensive residual cancer cases in response to neoadjuvant chemotherapy [C] . Mirella L. Altoe, Jacqueline E. Gunther, Emerson Lim, Optical tomography and spectroscopy of tissue XII . 2017

机译：新辅助化疗对病理完全缓解者和广泛残留癌病例基线氧饱和度的比较
5. Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies [O] . Sinead Toomey, Alexander J. Eustace, Joanna Fay, 2017

机译：体细胞PI3K途径和ERBB家族突变对接受新辅助HER2靶向治疗的HER2阳性乳腺癌患者的病理完全缓解（pCR）的影响
6. Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies. [O] . Toomey, Sinead, Eustace, Alex J, Fay, Joanna, 2017

机译：体细胞PI3K途径和ERBB家族突变对接受新辅助HER2靶向治疗的HER2阳性乳腺癌患者的病理完全缓解（pCR）的影响。

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号